The High Cost of Drugs, Profit Incentives, and Alternative Models for Pharmaceutical Companies

This chapter explores the high cost of drugs for diseases like AIDS and discusses the contrast between wealthy western countries and Africa. It delves into the argument for profit incentives in pharmaceutical companies, questions the relevance of patents and copyrights, and suggests the need for a more democratic system of medicine.